Brought to you by:
Intermittent claudication and exercise therapy: A poor SET-up
Many of you may have already heard about the controversial Comparative Billing Reports (CBRs) that have been received by some of our vascular surgery colleagues. In case you haven’t, this is your chance to catch up and to prepare for…
The top 10 most popular stories from April
Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels) at vascular surgery meetings, and some of the latest details on the 2021 Vascular Annual Meeting…
MicroStent to treat PAD below the knee receives FDA breakthrough device designation
Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed to achieve and maintain vessel patency, enhance wound treatment and improve quality of life and blood…
Interventions associated with ‘poor’ two-year relief of intermittent claudication symptoms
Peripheral vascular interventions for intermittent claudication were linked to “poor” two-year relief of symptoms in the Vascular Quality Initiative (VQI) database, a new study published in the May issue of the Journal of Vascular Surgery (JVS) found. First-named author Jonathan…
SoundBite peripheral crossing system gains FDA approval
Soundbite Medical Solutions has announced Food and Drug Administration (FDA) 510(k) approval for the SoundBite crossing system—Peripheral (SCS-P) with the 0.014” active wire (14P). The SoundBite crossing system—Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional…
PAD: Endologix acquires PQ Bypass
Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD). PQ Bypass’ proprietary Detour platform for percutaneous femoropopliteal bypass has been designated by the Food and…
Lessons in PAD care from VA vascular surgeons
The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations, infection, ischemia and comorbidities, we can accomplish amazing things. In an ideal world, our approaches universally…
Surmodics announces first patient uses of two Sublime radial access platform devices
Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath and Sublime radial access .014 RX percutaneous transluminal angioplasty (PTA) dilatation catheter. Constantino Pena, MD, Andrew Niekamp,…
Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy
No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare expenditure associated with the procedure is substantial, write Caitlin W. Hicks MD, assistant professor of surgery at John…
SVS SET: PAD patient walks away from pain
Ice, cold and snow make it tough to walk outside in Lansing, Michigan, right now. So, jokes Doug Giller, he is wearing a path in his carpeting instead. For 45 minutes each evening, he walks a path throughout his house…